FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine
This article was originally published in The Pink Sheet Daily
Historically overlooked office gets leadership, money and hiring okay needed to ramp up its contribution to pan-FDA initiatives, policy discussions.
You may also be interested in...
Industry leaders disagree on whether collaborations or mergers are the best structure for effective drug/diagnostic collaborations
Peer Portner: The pioneer of the first electrical left ventricular assist device died Feb. 9, from cancer. Peer Portner, a Ph.D. trained in nuclear physics, lead a multidisciplinary team at Stanford University in the 1970s to develop the Novacor LVAD, used in the first bridge-to-transplant procedure in 1984. Portner also founded Novacor Medical, which was acquired by Baxter Healthcare in 1988. WorldHeart acquired the Novacor technology in 2000 and continues to market, on a limited basis, an updated version of the product as a bridge-to-transplant pump, and, in Europe, as a longer-term destination therapy
Recently appointed leaders of CDRH's new cross-center post-market safety "matrix" organization are officially on the job, beginning July 14, after six months of initial training and testing of the collaborative system